Hypothalamo-pituitary-adrenal axis responses to lipopolysaccharide in male and female rats with adjuvant-induced arthritis

Brain, Behavior, and Immunity

Volumn 13, Issue 4, 1999, Pages 335-347

  Harbuz, M S ^a   Rooney, C ^b   Jones, M ^a   Ingram, C D ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

ACTH; Adjuvant induced arthritis; Corticosterone; Corticotropin releasing factor; Hypothalamo pituitary adrenal axis; Inflammation; Lipopolysaccharide; POMC

Indexed keywords

GLUCOCORTICOID; LIPOPOLYSACCHARIDE;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INFLAMMATION; MALE; MENTAL STRESS; NONHUMAN; PHYSICAL STRESS; PRIORITY JOURNAL; RAT;

EID: 0033462226     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1998.0536     Document Type: Article

References (49)

1. Aguilera G., Jessop D. S., Harbuz M. S., Kiss A., Lightman S. L. Biphasic regulation of hypothalamic-pituitary corticotropin releasing hormone receptors during development of adjuvant-induced arthritis in the rat. J. Endocrinol. 153:1997;185-191.
2. Banks W. A., Kastin A. J., Broadwell R. D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation. 2:1995;241-248.
3. Berkenbosch F., De Goeij D. E. C., Del Rey A., Besedovsky H. O. Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1. Neuroendocrinology. 50:1989;570-576.
4. Berkenbosch F., Van Oers J., Del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science. 238:1987;524-526.
5. Bertini R., Bianchi M., Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 167:1988;1708-1712.
6. Brady L. S., Page S. W., Thomas F. S., Rader J. L., Lynn A. B., Misiewicz-Poltorak B., Zelazowski E., Crofford L. J., Zelazowski P., Smith C., Raybourne R. B., Love L. A., Gold P. W., Sternberg E. M. 1′1-Ethylidenebis[l-tryptophan], a contaminant implicated in l-tryptophan eosinophilia myalgia syndrome, suppresses mRNA expression of hypothalamic corticotropin-releasing hormone in Lewis (LEW/N) rat brain. Neuroimmunomodulation. 1:1994;59-65.
7. Burrought M., Cabellos C., Prasad S., Tuomanen E. Bacterial components and the pathophysiology of injury to the blood-brain barrier:Does cell wall add to the effects of endotoxin in gram-negative meningitis. J. Infect. Dis. 165:1992;S82-S85.
8. Cambronero J. C., Borrell J., Guaza C. Glucocorticoids modulate rat hypothalamic corticotrophin-releasing factor release induced by interleukin-1. J. Neurosci. Res. 24:1989;470-476.
9. Chikanza I. C., Petrou P., Kimgsley G., Chrousos G., Panayi G. S. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 35:1992;1281-1288.
10. Chover-Gonzalez A. J., Harbuz M. S., Lightman S. L. Effect of adrenalectomy and stress on interleukin-1β mediated activation of hypothalamic corticotropin releasing factor mRNA. J. Neuroimmunol. 42:1993;155-160.
11. Chover-Gonzalez A. J., Tejedor-Real P., Harbuz M. S., Gibert-Rahola J., Larsen P. J., Jessop D. S. A differential response to stress is not a prediction of susceptibility or severity in adjuvant-induced arthritis. Stress. 2:1998;1-6.
12. Chowdrey H. S., Larsen P. J., Harbuz M. S., Lightman S. L., Jessop D. S. Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stress. Life Sci. 57:1995;2021-2029.
13. Cunningham E. T., DeSouza E. Interleukin-1 receptors in the brain and endocrine tissues. Immunol. Today. 14:1994;161-176.
14. Cunningham E. T., Sawchenko P. E. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J. Comp. Neurol. 274:1988;60-76.
15. deVries H. E., Blom-Roosmalen M. C. M., vanOosten M., deBoer A. G., vanBerkel T. J. C., Briemer D. D., Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64:1996;37-43.
16. Ericsson A., Liu C., Hart R. P., Sawchenko P. E. Type I interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 361:1995;681-698.
17. Fleshner M., Goehler L. E., Hermann J., Relton J. K., Maier S. F., Watkins L. R. Interleukin-1β induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res. Bull. 37:1995;605-610.
18. Gaykema R. P. A., Dijkstra I., Tilders F. J. H. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology. 136:1995;4717-4720.
19. Harbuz M. S., Conde G. L., Marti O., Lightman S. L., Jessop D. S. The hypothalamic-pituitary-adrenal axis in autoimmunity. Ann. N.Y. Acad. Sci. 823:1997;214-224.
20. Harbuz M. S., Jessop D. S., Chowdrey H. S., Blackwell J. M., Larsen P. J., Lightman S. L. Evidence for altered control of hypothalamic CRF in immune-mediated diseases. Ann. N.Y. Acad. Sci. 771:1995;449-458.
21. Harbuz M. S., Leonard J. P., Lightman S. L., Cuzner M. L. Changes in hypothalamic corticotrophin releasing factor (CRF) and pituitary proopiomelanocortin (POMC) messenger RNA during the course of experimental allergic encephalomyelitis (EAE). J. Neuroimmunol. 45:1993;127-132.
22. Harbuz M. S., Lightman S. L. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J. Endocrinol. 122:1989;705-711.
23. Harbuz M. S., Lightman S. L. Stress and the hypothalamo-pituitary-adrenal axis: Acute, chronic and immunological activation. J. Endocrinol. 134:1992;327-339.
24. Harbuz M. S., Rees R. G., Eckland D., Jessop D. S., Brewerton D., Lightman S. L. Paradoxical responses of hypothalamic CRF mRNA and CRF-41 peptide and adenohypophyseal POMC mRNA during chronic inflammatory stress. Endocrinology. 130:1992;1394-1400.
25. Harbuz M. S., Rees R. G., Lightman S. L. Hypothalamo-pituitary responses to acute stress and changes in circulating glucocorticoids during chronic adjuvant-induced arthritis in the rat. Am. J. Physiol. 264:1993;R179-R185.
26. Jessop D. S., Eckland D. J., Todd K., Lightman S. L. Osmotic regulation of hypothalamo-neurointermediate lobe corticotrophin-releasing factor-41 in the rat. J. Endocrinol. 120:1989;119-124.
27. Kapcala L. P., He J. R., Gao Y., Pieper J. O., DeTolla L. J. Subdiaphagmatic vagotomy inhibits intra-abdominal interleukin-1β stimulation of adrenocorticotropin secretion. Brain Res. 728:1996;247-254.
28. Lightman S. L., Harbuz M. S., Knight R. A., Chowdrey H. S. CRF mRNA in normal and stress conditions. Ann. N.Y. Acad. Sci. 697:1993;28-38.
29. Lightman S. L., Young W. S. III. Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress. Proc. Natl. Acad. Sci. USA. 86:1989;4306-4310.
30. MacPhee I. A., Antoni F. A., Mason D. W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169:1989;431-435.
31. Mason D. Genetic variation in the stress response; Susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol. Today. 12:1991;57-60.
32. Millan M. J., Millan M. H., Czlonkowski A., Hollt V., Pilcher C. W. T., Herz A., Colpaert F. C. A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritis. J. Neurosci. 6:1986;899-906.
33. Munck A., Guyre P. M., Holbrook N. J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5:1984;25-44.
34. Navarra P., Tsagarakis S., Faria M. S., Rees L. H., Besser G. M., Grossman A. B. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology. 128:1991;37-44.
35. Plotkin S. R., Banks W. A., Kastin A. J. Comparison of saturable transport and extracellular pathways in the passage of interleukin-1a across the blood-brain barrier. J. Neuroimmunol. 67:1996;41-47.
36. Reincke M., Heppner C., Petske F., Allolio B., Arlt W., Mbulamberi D., Siekmann L., Vollmer D., Winkelmann W., Chrousos G. P. Impairment of adrenocortical function associated with increased plasma tumour necrosis factor-alpha and interleukin-6 concentrations in African trypanosomiasis. Neuroimmunomodulation. 1:1994;14-22.
37. Rittenhouse P. A., Redei E. Thyroxine administration prevents streptococcal cell wall-induced inflammatory responses. Endocrinology. 138:1997;1434-1439.
38. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 238:1987;522-524.
39. Sarlis N. J., Chowdrey H. S., Stephanou A., Lightman S. L. Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinology. 130:1992;1775-1779.
40. Shanks N., Moore P. M., Perks P., Lightman S. L. Endocrine correlates of murine systemic lupus erythematosus in the MRL lpr/lpr model. Ann. N.Y. Acad. Sci. 823:1997;252-255.
41. Stephanou A., Sarlis N. J., Knight R. A., Chowdrey H. S., Lightman S. L. Response of pituitary and spleen POMC mRNA and spleen and thymus interleukin-1β mRNA to adjuvant arthritis. J. Neuroimmunol. 37:1992;59-63.
42. Sternberg E. M., Young W. S. III, Bernardini R., Calogero A. E., Chrousos G. P., Gold P. W., Wilder R. L. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with the susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. USA. 86:1989;4771-4775.
43. Suda T., Tozawa F., Ushiyama T., Sumitomo T., Yamada M., Demura H. Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology. 126:1990;1223-1228.
44. Tsagarakis S., Gillies G., Rees L. H., Besser M., Grossman A. Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus. Neuroendocrinology. 49:1989;98-101.
45. van de Langerijt A. G., van Lent P. L., Hermus A. R., Sweep C. G., Cools A. R., van den Berg W. B. Susceptibility to adjuvant arthritis: Relative importance of adrenal activity and bacterial flora. Clin. Exp. Immunol. 97:1994;33-38.
46. Watanabe T., Morimoto A., Sakata Y., Murakami N. ACTH response induced by interleukin-1 is mediated by CRF secretion stimulated by hypothalamic PGE. Experientia. 46:1990;481-484.
47. Weidenfeld J., Abramsky O., Ovadia H. Effect of interleukin-1 on ACTH and corticosterone secretion in dexamethasone and adrenalectomized pretreated male rats. Neuroendocrinology. 50:1989;650-654.
48. Wick G., Hu Y., Schwarz S., Kroemer G. Immunoneuroendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr. Rev. 14:1993;539-563.
49. Young W. S. III, Mezey E., Siegel R. E. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci. Lett. 70:1986;198-203.